Fertility Medical Billing Overview
Fertility and reproductive endocrinology billing sits at one of the most technically demanding intersections in healthcare revenue cycle management. The specialty spans diagnostic workups under ICD-10 codes N97.0 through N97.9, surgical interventions including hysteroscopy and laparoscopy, and highly variable coverage determinations for assisted reproductive technology (ART) procedures. Since the landmark Affordable Care Act did not mandate ART coverage federally, fertility billing operates in a patchwork of state mandates, employer plan carve-outs, and fertility benefit managers (FBMs) such as Progyny, WINFertility, and Carrot that function as a separate benefits layer entirely distinct from the patient’s primary medical carrier.
State mandates complicate payer adjudication significantly. As of 2026, 21 states plus the District of Columbia have enacted fertility insurance mandates, but the scope differs materially: some mandate IVF coverage, others limit coverage to diagnosis and intrauterine insemination (IUI). New York, Massachusetts, and Illinois carry the broadest mandates, while states like Texas have no mandate at all. Practices billing BCBS of Illinois face a fundamentally different coverage environment than practices billing BCBS of Texas, even when using identical CPT codes for the same procedure. Understanding these state-level variables is not optional; it is the baseline requirement for accurate fertility billing.
Common Billing Challenges in Fertility
- FBM coordination with primary insurance: When patients carry both a primary medical plan through UnitedHealthcare or Aetna and a separate fertility benefit through Progyny or WINFertility, claims must be routed to the correct payer for each line item. Submitting ART claims to the medical carrier when the patient has an active fertility benefit triggers automatic denials and delays payment by weeks.
- Global package vs. per-service billing: Many fertility practices bill IVF as a global package, but payers including Cigna and Humana adjudicate per-service claims differently than global bundles. Mismatching the claim format to payer expectations results in partial payment or complete rejection with no explanation beyond a generic code mismatch denial.
- Monitoring cycle coding: Ovulation induction monitoring visits involve E/M codes, ultrasound codes (76857, 76830), and estradiol/FSH lab interpretations. Each component must be separately documented and billed. Bundling these services into a single monitoring charge without code differentiation routinely underpays the practice by $80 to $150 per monitoring visit.
- IVF procedure code specificity: CPT 58970 (follicle puncture for oocyte retrieval), 58974 (embryo transfer), and 89258 (cryopreservation of embryos) require precise documentation including cycle dates, embryo counts, and procedural notes. Missing any of these elements triggers medical review requests that stall payment for 30 to 60 days.
Key CPT Codes for Fertility Billing
- 58970: Follicle puncture for oocyte retrieval, the core IVF retrieval procedure code billed to fertility benefits or mandated medical plans
- 58974: Embryo transfer, intrauterine, the transfer component of an IVF cycle requiring distinct documentation from the retrieval
- 89258: Cryopreservation of embryo(s), billed separately from the IVF cycle when applicable under the patient’s benefit structure
- 58321: Artificial insemination, intrauterine (IUI), the primary code for IUI procedures covered under most state mandates
- 76830: Ultrasound, transvaginal, the monitoring ultrasound code used throughout stimulation cycles for follicle measurement
Revenue Cycle Considerations for Fertility
Fertility practices face average A/R days between 45 and 65, substantially higher than most surgical specialties, primarily because of the multi-payer coordination complexity and the frequency of coverage verification failures before treatment begins. First-pass denial rates in fertility billing average 18 to 24 percent, compared to a 5 to 10 percent benchmark in orthopedics or cardiology. The leading denial categories are authorization failures, benefit exhaustion without prior notification to the practice, and incorrect payer routing when FBMs are involved.
Payer mix analysis is critical for fertility practices because a single IVF cycle can generate $8,000 to $15,000 in charges. A claim denied and not appealed correctly within the payer’s timely filing window results in a complete write-off of that revenue. Medicare covers fertility diagnosis workups but excludes ART procedures entirely under 42 CFR 410.79. Medicaid coverage for ART is extremely limited and varies by state. The bulk of fertility revenue runs through commercial payers including BCBS state plans, UnitedHealthcare, Aetna, and FBMs, making commercial payer contract management and credentialing a revenue-critical priority.
How My Medical Bill Solution Helps Fertility Practices
My Medical Bill Solution provides fertility-specific billing expertise that accounts for the FBM layer, state mandate variations, and the per-cycle documentation requirements that determine whether a claim pays in full or generates a denial cascade. The intake process includes a comprehensive payer verification workflow that confirms ART benefits, cycle limits, prior authorization requirements, and FBM coordination before any treatment begins. That front-end accuracy is what prevents the back-end denials that erode fertility practice revenue. Contact My Medical Bill Solution to schedule a free billing assessment for your reproductive endocrinology or fertility practice.